Publications by authors named "Ingo Hartlapp"

Claim this Profile
I
Indicator-condition-guided HIV testing in rural DRC.
Pascal Migaud, Julia Naidenow, Leyli Ghaeni, Kai Hosmann, Jeannine Kaghoma, Ingo Hartlapp

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.
Ingo Hartlapp, Philipp E Hartrampf, Sebastian E Serfling, Vanessa Wild, Alexander Weich

J Nucl Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Concurrent Cholestasis Alter the Prognostic Value of Preoperatively Elevated CA19-9 Serum Levels in Patients with Pancreatic Head Adenocarcinoma?
Friedrich Anger, Johan Friso Lock, Ingo Klein, Ingo Hartlapp, Armin Wiegering

Ann Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Volker Kunzmann, Jens T Siveke, Hana Algül, Eray Goekkurt, Gabriele Siegler, Ingo Hartlapp

Lancet Gastroenterol Hepatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer.
Volker Kunzmann, Ken Herrmann, Christina Bluemel, Markus Kapp, Ingo Hartlapp

Case Rep Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete pathological remission of locally advanced, unresectable pancreatic cancer (LAPC) after intensified neoadjuvant chemotherapy.
Ingo Hartlapp, Justus Müller, Werner Kenn, Ulrich Steger, Christoph Isbert

Onkologie· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines.
Ingo Hartlapp, Christian Pallasch, Ganna Weibert, Andrea Kemkers, Michael Hummel

Leuk Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of CARMA1/BCL10/MALT1 expression in Reed-Sternberg cells of classical Hodgkin lymphoma.
Daniel Re, Ingo Hartlapp, Axel Greiner, Volker Diehl, Claudia Wickenhauser

Leuk Lymphoma· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A recombinant bispecific single-chain antibody induces targeted, supra-agonistic CD28-stimulation and tumor cell killing.
Ludger Grosse-Hovest, Ingo Hartlapp, Wolfgang Marwan, Gottfried Brem, Hans-Georg Rammensee

Eur J Immunol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis